Veerman MW - Search Results

1

Pharmacokinetics and effectiveness of recombinant erythropoietin administered to preterm infants by continuous infusion in total parenteral nutrition solution.

Ohls RK, Veerman MW, Christensen RD. Ohls RK, et al. Among authors: veerman mw. J Pediatr. 1996 Apr;128(4):518-23. doi: 10.1016/s0022-3476(96)70363-3. J Pediatr. 1996. PMID: 8618186 Clinical Trial.

2

Granulocyte colony-stimulating factor serum and urine concentrations in neutropenic neonates before and after intravenous administration of recombinant granulocyte colony-stimulating factor.

Calhoun DA, Lunøe M, Du Y, Hutson AD, Veerman M, Christensen RD. Calhoun DA, et al. Pediatrics. 2000 Feb;105(2):392-7. doi: 10.1542/peds.105.2.392. Pediatrics. 2000. PMID: 10654961

3

Stability of filgrastim and epoetin alfa in a system designed for enteral administration in neonates.

Calhoun DA, Juul SE, McBryde EV, Veerman MW, Christensen RD. Calhoun DA, et al. Among authors: veerman mw. Ann Pharmacother. 2000 Nov;34(11):1257-61. doi: 10.1345/aph.10105. Ann Pharmacother. 2000. PMID: 11098337

4

Enteral glutamine supplementation for very low birth weight infants decreases morbidity.

Neu J, Roig JC, Meetze WH, Veerman M, Carter C, Millsaps M, Bowling D, Dallas MJ, Sleasman J, Knight T, Auestad N. Neu J, et al. J Pediatr. 1997 Nov;131(5):691-9. doi: 10.1016/s0022-3476(97)70095-7. J Pediatr. 1997. PMID: 9403648 Clinical Trial.

5

Enteral glutamine supplementation for the very low birthweight infant: plasma amino acid concentrations.

Roig JC, Meetze WH, Auestad N, Jasionowski T, Veerman M, McMurray CA, Neu J. Roig JC, et al. J Nutr. 1996 Apr;126(4 Suppl):1115S-20S. doi: 10.1093/jn/126.suppl_4.1115S. J Nutr. 1996. PMID: 8642443 Clinical Trial. No abstract available.

6

Use of activated charcoal to reduce elevated serum phenobarbital concentration in a neonate.

Veerman M, Espejo MG, Christopher MA, Knight M. Veerman M, et al. J Toxicol Clin Toxicol. 1991;29(1):53-8. doi: 10.3109/15563659109038597. J Toxicol Clin Toxicol. 1991. PMID: 2005666

7

Relative bioavailability and stability of extemporaneously prepared valproic acid emulsion.

Veerman MW, Hatton RC, Knight ME. Veerman MW, et al. Clin Pharm. 1991 May;10(5):382-4. Clin Pharm. 1991. PMID: 2049900 No abstract available.

8

Cost-effectiveness of RespiGam at a university teaching hospital.

Veerman M, Reuman P, Burchfield D, Sherman J. Veerman M, et al. Pediatrics. 1997 Jul;100(1):160-1. doi: 10.1542/peds.100.1.160. Pediatrics. 1997. PMID: 9229713 No abstract available.

9

Excipients in valproic acid syrup may cause diarrhea: a case report.

Veerman MW. Veerman MW. DICP. 1990 Sep;24(9):832-3. doi: 10.1177/106002809002400907. DICP. 1990. PMID: 2260339

10

Influence of two piston-type infusion pumps on hemolysis of infused red blood cells.

Veerman MW, Leff RD, Roberts RJ. Veerman MW, et al. Am J Hosp Pharm. 1985 Mar;42(3):626-8. Am J Hosp Pharm. 1985. PMID: 3985030 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

10 results

Search Page

Filters